Contact this trialFirst, we need to learn more about you.
Neurotoxin
AGN-151586 +1 More for Frown Lines
Recruiting1 awardPhase 3
Westmount, Quebec
This trial is testing a new product, AGN-151586, to see if it is safe and effective in treating moderate to severe glabellar lines (frown lines). The study is double-blind, meaning that neither the participant nor the researcher will know who is receiving AGN-151586 or Placebo. The study will last for 12 weeks, and participants will be given 5 intramuscular injections on the first day. Participants may be eligible for open-label treatment during the study if they meet certain criteria.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.